Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects.

Bakker GJ, Schnitzler JG, Bekkering S, de Clercq NC, Koopen AM, Hartstra AV, Meessen ECE, Scheithauer TP, Winkelmeijer M, Dallinga-Thie GM, Cani PD, Kemper EM, Soeters MR, Kroon J, Groen AK, van Raalte DH, Herrema H, Nieuwdorp M.

Physiol Rep. 2019 Aug;7(16):e14199. doi: 10.14814/phy2.14199.

2.

N-Glycosylation Defects in Humans Lower Low-Density Lipoprotein Cholesterol Through Increased Low-Density Lipoprotein Receptor Expression.

van den Boogert MAW, Larsen LE, Ali L, Kuil SD, Chong PLW, Loregger A, Kroon J, Schnitzler JG, Schimmel AWM, Peter J, Levels JHM, Steenbergen G, Morava E, Dallinga-Thie GM, Wevers RA, Kuivenhoven JA, Hand NJ, Zelcer N, Rader DJ, Stroes ESG, Lefeber DJ, Holleboom AG.

Circulation. 2019 Jul 23;140(4):280-292. doi: 10.1161/CIRCULATIONAHA.118.036484. Epub 2019 May 23.

PMID:
31117816
3.

A 3-SNP gene risk score and a metabolic risk score both predict hypertriglyceridemia and cardiovascular disease risk.

Verbeek R, Oldoni F, Surendran RP, Zwinderman AH, Khaw KT, Stroes ESG, Wareham NJ, Boekholdt SM, Dallinga-Thie GM.

J Clin Lipidol. 2019 May - Jun;13(3):492-501. doi: 10.1016/j.jacl.2019.02.005. Epub 2019 Feb 25.

4.

Introduction to the thematic review series on different levels of genetic regulation of cardiovascular disease.

de Winther MPJ, Dallinga-Thie GM.

Atherosclerosis. 2019 Feb;281:148-149. doi: 10.1016/j.atherosclerosis.2018.12.014. Epub 2018 Dec 22. No abstract available.

PMID:
30658843
5.

A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia.

Reeskamp LF, Hartgers ML, Peter J, Dallinga-Thie GM, Zuurbier L, Defesche JC, Grefhorst A, Hovingh GK.

Circ Genom Precis Med. 2018 Dec;11(12):e002385. doi: 10.1161/CIRCGEN.118.002385.

PMID:
30562117
6.

Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance.

Surendran RP, Udayyapan SD, Clemente-Postigo M, Havik SR, Schimmel AWM, Tinahones F, Nieuwdorp M, Dallinga-Thie GM.

PLoS One. 2018 Nov 8;13(11):e0205858. doi: 10.1371/journal.pone.0205858. eCollection 2018.

7.

Corrigendum to "Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model." [Atherosclerosis 274 (July 2018) 120-127].

Nahon JE, Hoekstra M, Havik SR, Van Santbrink PJ, Dallinga-Thie GM, Kuivenhoven JA, Geerling JJ, Van Eck M.

Atherosclerosis. 2018 Dec;279:132. doi: 10.1016/j.atherosclerosis.2018.09.007. Epub 2018 Oct 8. No abstract available.

PMID:
30305237
8.

Use of plasma metabolomics to analyze phenotype-genotype relationships in young hypercholesterolemic females.

Zhang X, Rimbert A, Balder W, Zwinderman AH, Kuivenhoven JA, Dallinga-Thie GM, Groen AK.

J Lipid Res. 2018 Nov;59(11):2174-2180. doi: 10.1194/jlr.M088930. Epub 2018 Sep 28.

9.

Naturally Occurring Variants in LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Affect HDL (High-Density Lipoprotein) Metabolism Through ABCA1 (ATP-Binding Cassette A1) and SR-B1 (Scavenger Receptor Class B Type 1) in Humans.

Oldoni F, van Capelleveen JC, Dalila N, Wolters JC, Heeren J, Sinke RJ, Hui DY, Dallinga-Thie GM, Frikke-Schmidt R, Hovingh KG, van de Sluis B, Tybjærg-Hansen A, Kuivenhoven JA.

Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1440-1453. doi: 10.1161/ATVBAHA.117.310309. Epub 2018 May 31.

10.

Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects.

Bouter K, Bakker GJ, Levin E, Hartstra AV, Kootte RS, Udayappan SD, Katiraei S, Bahler L, Gilijamse PW, Tremaroli V, Stahlman M, Holleman F, van Riel NAW, Verberne HJ, Romijn JA, Dallinga-Thie GM, Serlie MJ, Ackermans MT, Kemper EM, Willems van Dijk K, Backhed F, Groen AK, Nieuwdorp M.

Clin Transl Gastroenterol. 2018 May 25;9(5):155. doi: 10.1038/s41424-018-0025-4.

11.

Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model.

Nahon JE, Hoekstra M, Havik SR, Van Santbrink PJ, Dallinga-Thie GM, Kuivenhoven JA, Geerling JJ, Van Eck M.

Atherosclerosis. 2018 Jul;274:120-127. doi: 10.1016/j.atherosclerosis.2018.05.008. Epub 2018 May 5. Erratum in: Atherosclerosis. 2018 Dec;279:132.

PMID:
29772480
12.

Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome.

Smits LP, Kootte RS, Levin E, Prodan A, Fuentes S, Zoetendal EG, Wang Z, Levison BS, Cleophas MCP, Kemper EM, Dallinga-Thie GM, Groen AK, Joosten LAB, Netea MG, Stroes ESG, de Vos WM, Hazen SL, Nieuwdorp M.

J Am Heart Assoc. 2018 Mar 26;7(7). pii: e008342. doi: 10.1161/JAHA.117.008342.

13.

The Role of (Modified) Lipoproteins in Vascular Function: A Duet Between Monocytes and the Endothelium.

Schnitzler JG, Dallinga-Thie GM, Kroon J.

Curr Med Chem. 2019;26(9):1594-1609. doi: 10.2174/0929867325666180316121015. Review.

PMID:
29546830
14.

Intestinal Ralstonia pickettii augments glucose intolerance in obesity.

Udayappan SD, Kovatcheva-Datchary P, Bakker GJ, Havik SR, Herrema H, Cani PD, Bouter KE, Belzer C, Witjes JJ, Vrieze A, de Sonnaville ESV, Chaplin A, van Raalte DH, Aalvink S, Dallinga-Thie GM, Heilig HGHJ, Bergström G, van der Meij S, van Wagensveld BA, Hoekstra JBL, Holleman F, Stroes ESG, Groen AK, Bäckhed F, de Vos WM, Nieuwdorp M.

PLoS One. 2017 Nov 22;12(11):e0181693. doi: 10.1371/journal.pone.0181693. eCollection 2017. Erratum in: PLoS One. 2018 Jan 30;13(1):e0192339.

15.

HDL functionality in type 1 diabetes.

Ganjali S, Dallinga-Thie GM, Simental-Mendía LE, Banach M, Pirro M, Sahebkar A.

Atherosclerosis. 2017 Dec;267:99-109. doi: 10.1016/j.atherosclerosis.2017.10.018. Epub 2017 Oct 21. Review.

PMID:
29102899
16.

Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition.

Kootte RS, Levin E, Salojärvi J, Smits LP, Hartstra AV, Udayappan SD, Hermes G, Bouter KE, Koopen AM, Holst JJ, Knop FK, Blaak EE, Zhao J, Smidt H, Harms AC, Hankemeijer T, Bergman JJGHM, Romijn HA, Schaap FG, Olde Damink SWM, Ackermans MT, Dallinga-Thie GM, Zoetendal E, de Vos WM, Serlie MJ, Stroes ESG, Groen AK, Nieuwdorp M.

Cell Metab. 2017 Oct 3;26(4):611-619.e6. doi: 10.1016/j.cmet.2017.09.008.

17.

Nile Red Quantifier: a novel and quantitative tool to study lipid accumulation in patient-derived circulating monocytes using confocal microscopy.

Schnitzler JG, Bernelot Moens SJ, Tiessens F, Bakker GJ, Dallinga-Thie GM, Groen AK, Nieuwdorp M, Stroes ESG, Kroon J.

J Lipid Res. 2017 Nov;58(11):2210-2219. doi: 10.1194/jlr.D073197. Epub 2017 Sep 28.

18.

ABCA8 Regulates Cholesterol Efflux and High-Density Lipoprotein Cholesterol Levels.

Trigueros-Motos L, van Capelleveen JC, Torta F, Castaño D, Zhang LH, Chai EC, Kang M, Dimova LG, Schimmel AWM, Tietjen I, Radomski C, Tan LJ, Thiam CH, Narayanaswamy P, Wu DH, Dorninger F, Yakala GK, Barhdadi A, Angeli V, Dubé MP, Berger J, Dallinga-Thie GM, Tietge UJF, Wenk MR, Hayden MR, Hovingh GK, Singaraja RR.

Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2147-2155. doi: 10.1161/ATVBAHA.117.309574. Epub 2017 Sep 7.

PMID:
28882873
19.

Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice.

Udayappan S, Manneras-Holm L, Chaplin-Scott A, Belzer C, Herrema H, Dallinga-Thie GM, Duncan SH, Stroes ESG, Groen AK, Flint HJ, Backhed F, de Vos WM, Nieuwdorp M.

NPJ Biofilms Microbiomes. 2016 Jul 6;2:16009. doi: 10.1038/npjbiofilms.2016.9. eCollection 2016.

20.

GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.

Hu X, Dallinga-Thie GM, Hovingh GK, Chang SY, Sandoval NP, Dang TLP, Fukamachi I, Miyashita K, Nakajima K, Murakami M, Fong LG, Ploug M, Young SG, Beigneux AP.

J Clin Lipidol. 2017 Jul - Aug;11(4):964-971. doi: 10.1016/j.jacl.2017.05.017. Epub 2017 Jun 13.

21.

Causality of small and large intestinal microbiota in weight regulation and insulin resistance.

Scheithauer TP, Dallinga-Thie GM, de Vos WM, Nieuwdorp M, van Raalte DH.

Mol Metab. 2016 Jun 10;5(9):759-70. doi: 10.1016/j.molmet.2016.06.002. eCollection 2016 Sep.

22.

Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?

Dallinga-Thie GM, Kroon J, Borén J, Chapman MJ.

Curr Cardiol Rep. 2016 Jul;18(7):67. doi: 10.1007/s11886-016-0745-6. Review.

23.

A loss-of-function variant in OSBPL1A predisposes to low plasma HDL cholesterol levels and impaired cholesterol efflux capacity.

Motazacker MM, Pirhonen J, van Capelleveen JC, Weber-Boyvat M, Kuivenhoven JA, Shah S, Hovingh GK, Metso J, Li S, Ikonen E, Jauhiainen M, Dallinga-Thie GM, Olkkonen VM.

Atherosclerosis. 2016 Jun;249:140-7. doi: 10.1016/j.atherosclerosis.2016.04.005. Epub 2016 Apr 11.

PMID:
27105157
24.

Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis.

van der Valk FM, Schulte DM, Meiler S, Tang J, Zheng KH, Van den Bossche J, Seijkens T, Laudes M, de Winther M, Lutgens E, Alaarg A, Metselaar JM, Dallinga-Thie GM, Mulder WJ, Stroes ES, Hamers AA.

Nanomedicine. 2016 Aug;12(6):1463-70. doi: 10.1016/j.nano.2016.02.022. Epub 2016 Mar 23.

PMID:
27015770
25.

Role of sulfatase 2 in lipoprotein metabolism and angiogenesis.

Dallinga MG, Dallinga-Thie GM.

Curr Opin Lipidol. 2016 Apr;27(2):181-6. doi: 10.1097/MOL.0000000000000271. Review.

PMID:
26959705
26.

Higher Plasma ApoE Levels are Associated with Low-Normal Thyroid Function: Studies in Diabetic and Nondiabetic Subjects.

van Tienhoven-Wind LJ, Dallinga-Thie GM, Dullaart RP.

Horm Metab Res. 2016 Jul;48(7):462-7. doi: 10.1055/s-0042-102883. Epub 2016 Feb 25.

PMID:
26916531
27.

Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles.

Dullaart RPF, Gruppen EG, Dallinga-Thie GM.

Clin Biochem. 2016 Apr;49(6):508-510. doi: 10.1016/j.clinbiochem.2015.11.017. Epub 2015 Dec 2.

PMID:
26656640
28.

GLP1, an Important Regulator of Intestinal Lipid Metabolism.

Dallinga-Thie GM, Nieuwdorp M.

Arterioscler Thromb Vasc Biol. 2015 May;35(5):1048-9. doi: 10.1161/ATVBAHA.115.305479. No abstract available.

PMID:
25903650
29.

A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis.

Maiwald S, Motazacker MM, van Capelleveen JC, Sivapalaratnam S, van der Wal AC, van der Loos C, Kastelein JJ, Ouwehand WH, Hovingh GK, Trip MD, van Buul JD, Dallinga-Thie GM.

Eur J Hum Genet. 2016 Jan;24(1):86-91. doi: 10.1038/ejhg.2015.70. Epub 2015 Apr 22.

30.

Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration.

van der Valk FM, van Wijk DF, Lobatto ME, Verberne HJ, Storm G, Willems MC, Legemate DA, Nederveen AJ, Calcagno C, Mani V, Ramachandran S, Paridaans MP, Otten MJ, Dallinga-Thie GM, Fayad ZA, Nieuwdorp M, Schulte DM, Metselaar JM, Mulder WJ, Stroes ES.

Nanomedicine. 2015 Jul;11(5):1039-46. doi: 10.1016/j.nano.2015.02.021. Epub 2015 Mar 17.

31.

Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans.

Mooij HL, Bernelot Moens SJ, Gordts PL, Stanford KI, Foley EM, van den Boogert MA, Witjes JJ, Hassing HC, Tanck MW, van de Sande MA, Levels JH, Kastelein JJ, Stroes ES, Dallinga-Thie GM, Esko JD, Nieuwdorp M.

J Lipid Res. 2015 Mar;56(3):665-73. doi: 10.1194/jlr.M053504. Epub 2015 Jan 7.

32.

Carriers of loss-of-function mutations in EXT display impaired pancreatic beta-cell reserve due to smaller pancreas volume.

Bernelot Moens SJ, Mooij HL, Hassing HC, Kruit JK, Witjes JJ, van de Sande MA, Nederveen AJ, Xu D, Dallinga-Thie GM, Esko JD, Stroes ES, Nieuwdorp M.

PLoS One. 2014 Dec 26;9(12):e115662. doi: 10.1371/journal.pone.0115662. eCollection 2014.

33.

Annexin A5 haplotypes in familial hypercholesterolemia: lack of association with carotid intima-media thickness and cardiovascular disease risk.

Hiddink L, Dallinga-Thie GM, Hovingh GK, de Visser MC, Peer PG, Stalenhoef AF, van Heerde WL.

Atherosclerosis. 2015 Feb;238(2):195-200. doi: 10.1016/j.atherosclerosis.2014.11.023. Epub 2014 Nov 29.

PMID:
25525746
34.

Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function.

Mooij HL, Cabrales P, Bernelot Moens SJ, Xu D, Udayappan SD, Tsai AG, van der Sande MA, de Groot E, Intaglietta M, Kastelein JJ, Dallinga-Thie GM, Esko JD, Stroes ES, Nieuwdorp M.

J Am Heart Assoc. 2014 Dec 2;3(6):e001274. doi: 10.1161/JAHA.114.001274.

35.

Increased large VLDL particles confer elevated cholesteryl ester transfer in diabetes.

Dullaart RP, de Vries R, Kwakernaak AJ, Perton F, Dallinga-Thie GM.

Eur J Clin Invest. 2015 Jan;45(1):36-44. doi: 10.1111/eci.12377.

PMID:
25402623
36.

Phospholipid transfer protein activity and incident type 2 diabetes mellitus.

Abbasi A, Dallinga-Thie GM, Dullaart RP.

Clin Chim Acta. 2015 Jan 15;439:38-41. doi: 10.1016/j.cca.2014.09.035. Epub 2014 Oct 7.

PMID:
25304745
37.

Adipocyte ATP-binding cassette G1 promotes triglyceride storage, fat mass growth, and human obesity.

Frisdal E, Le Lay S, Hooton H, Poupel L, Olivier M, Alili R, Plengpanich W, Villard EF, Gilibert S, Lhomme M, Superville A, Miftah-Alkhair L, Chapman MJ, Dallinga-Thie GM, Venteclef N, Poitou C, Tordjman J, Lesnik P, Kontush A, Huby T, Dugail I, Clement K, Guerin M, Le Goff W.

Diabetes. 2015 Mar;64(3):840-55. doi: 10.2337/db14-0245. Epub 2014 Sep 23.

38.

Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia.

Fouchier SW, Dallinga-Thie GM, Meijers JC, Zelcer N, Kastelein JJ, Defesche JC, Hovingh GK.

Circ Res. 2014 Aug 29;115(6):552-5. doi: 10.1161/CIRCRESAHA.115.304660. Epub 2014 Jul 17.

PMID:
25035151
39.

Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions.

Hoeksema MA, Gijbels MJ, Van den Bossche J, van der Velden S, Sijm A, Neele AE, Seijkens T, Stöger JL, Meiler S, Boshuizen MC, Dallinga-Thie GM, Levels JH, Boon L, Mullican SE, Spann NJ, Cleutjens JP, Glass CK, Lazar MA, de Vries CJ, Biessen EA, Daemen MJ, Lutgens E, de Winther MP.

EMBO Mol Med. 2014 Sep;6(9):1124-32. doi: 10.15252/emmm.201404170.

40.

Towards network analysis to understand the genetic architecture of blood lipids: do the inclusion of age-dependency helps to identify seven novel loci?

Dallinga-Thie GM, Hovingh GK.

Atherosclerosis. 2014 Aug;235(2):642-3. doi: 10.1016/j.atherosclerosis.2014.05.947. Epub 2014 Jun 17. No abstract available.

PMID:
24973594
41.

Mutation in KERA identified by linkage analysis and targeted resequencing in a pedigree with premature atherosclerosis.

Maiwald S, Sivapalaratnam S, Motazacker MM, van Capelleveen JC, Bot I, de Jager SC, van Eck M, Jolley J, Kuiper J, Stephens J, Albers CA, Vosmeer CR, Kruize H, Geerke DP, van der Wal AC, van der Loos CM, Kastelein JJ, Trip MD, Ouwehand WH, Dallinga-Thie GM, Hovingh GK.

PLoS One. 2014 May 30;9(5):e98289. doi: 10.1371/journal.pone.0098289. eCollection 2014.

42.

Abnormal hemostatic parameters in patients with myocardial infarction but angiographically normal coronary arteries.

Maiwald S, Oey RC, Sivapalaratnam S, Bakhtiari K, Hovingh GK, Basart DC, Trip MD, Dallinga-Thie GM.

Int J Cardiol. 2014 Jul 1;174(3):734-5. doi: 10.1016/j.ijcard.2014.04.099. Epub 2014 Apr 14. No abstract available.

PMID:
24780546
43.

Hepatic transforming growth factor-β 1 stimulated clone-22 D1 controls systemic cholesterol metabolism.

Jäger J, Greiner V, Strzoda D, Seibert O, Niopek K, Sijmonsma TP, Schäfer M, Jones A, De Guia R, Martignoni M, Dallinga-Thie GM, Diaz MB, Hofmann TG, Herzig S.

Mol Metab. 2014 Jan 8;3(2):155-66. doi: 10.1016/j.molmet.2013.12.007. eCollection 2014 Apr.

44.

Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus.

Udayappan SD, Hartstra AV, Dallinga-Thie GM, Nieuwdorp M.

Clin Exp Immunol. 2014 Jul;177(1):24-9. doi: 10.1111/cei.12293. Review.

45.

HDL does not influence the polarization of human monocytes toward an alternative phenotype.

Colin S, Fanchon M, Belloy L, Bochem AE, Copin C, Derudas B, Stroes ES, Hovingh GK, Kuivenhoven JA, Dallinga-Thie GM, Staels B, Chinetti-Gbaguidi G.

Int J Cardiol. 2014 Mar 1;172(1):179-84. doi: 10.1016/j.ijcard.2013.12.168. Epub 2014 Jan 8.

PMID:
24456889
46.

SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus.

Hassing HC, Surendran RP, Derudas B, Verrijken A, Francque SM, Mooij HL, Bernelot Moens SJ, Hart LM, Nijpels G, Dekker JM, Williams KJ, Stroes ES, Van Gaal LF, Staels B, Nieuwdorp M, Dallinga-Thie GM.

Obesity (Silver Spring). 2014 May;22(5):1309-16. doi: 10.1002/oby.20682. Epub 2014 Jan 9.

47.

The endoplasmic reticulum coat protein II transport machinery coordinates cellular lipid secretion and cholesterol biosynthesis.

Fryer LG, Jones B, Duncan EJ, Hutchison CE, Ozkan T, Williams PA, Alder O, Nieuwdorp M, Townley AK, Mensenkamp AR, Stephens DJ, Dallinga-Thie GM, Shoulders CC.

J Biol Chem. 2014 Feb 14;289(7):4244-61. doi: 10.1074/jbc.M113.479980. Epub 2013 Dec 13.

48.

Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.

Vrieze A, Out C, Fuentes S, Jonker L, Reuling I, Kootte RS, van Nood E, Holleman F, Knaapen M, Romijn JA, Soeters MR, Blaak EE, Dallinga-Thie GM, Reijnders D, Ackermans MT, Serlie MJ, Knop FK, Holst JJ, van der Ley C, Kema IP, Zoetendal EG, de Vos WM, Hoekstra JB, Stroes ES, Groen AK, Nieuwdorp M.

J Hepatol. 2014 Apr;60(4):824-31. doi: 10.1016/j.jhep.2013.11.034. Epub 2013 Dec 6.

PMID:
24316517
49.

Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.

Rensing KL, de Jager SC, Stroes ES, Vos M, Twickler MT, Dallinga-Thie GM, de Vries CJ, Kuiper J, Bot I, von der Thüsen JH.

Cardiovasc Res. 2014 Feb 1;101(2):277-87. doi: 10.1093/cvr/cvt252. Epub 2013 Nov 12.

PMID:
24220638
50.

The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome.

Dullaart RP, Kwakernaak AJ, Dallinga-Thie GM.

Atherosclerosis. 2013 Sep;230(1):6-11. doi: 10.1016/j.atherosclerosis.2013.06.019. Epub 2013 Jul 1.

PMID:
23958245

Supplemental Content

Loading ...
Support Center